Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugsBMC Endocr Disord 2022 Oct 19;22(1)251, V Volke, U Katus, A Johannson, K Toompere, K Heinla, K Rünkorg, A Uusküla
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.